Global Patent Index - EP 1100475 A1

EP 1100475 A1 2001-05-23 - USE OF DRUG-LOADED NANOPARTICLES FOR THE TREATMENT OF CANCERS

Title (en)

USE OF DRUG-LOADED NANOPARTICLES FOR THE TREATMENT OF CANCERS

Title (de)

VERWENDUNG VON ARZNEISTOFFBELADENEN NANOPARTIKEL ZUR BEHANDLUNG VON KREBS

Title (fr)

UTILISATION DE NANOPARTICULES CHARGEES DE MEDICAMENT DANS LE TRAITEMENT ANTICANCEREUX

Publication

EP 1100475 A1 (EN)

Application

EP 99926509 A

Priority

EP 9903838 W

Abstract (en)

[origin: WO0074658A1] The present invention relates to the use of drug-loaded nanoparticles for preparing a medicament for the treatment of cancer, particularly for the treatment of cancer in the brain, even more particularly for the treatment of brain cancer in humans. The invention also relates to a process for the treatment of brain cancer, particularly for the treatment of brain cancer in humans by administering an effective amount of nanoparticles containing a substance which has effect in the cancer treatment or has immunosuppressive effects.

IPC 1-7 (main, further and additional classification)

A61K 9/51; A61K 31/70; A61P 35/00

IPC 8 full level (invention and additional information)

A61K 9/00 (2006.01); A61K 9/51 (2006.01); A61K 31/136 (2006.01); A61K 31/704 (2006.01); A61K 47/08 (2006.01); A61K 47/14 (2006.01); A61K 47/18 (2006.01); A61K 47/40 (2006.01); A61P 35/00 (2006.01)

CPC (invention and additional information)

A61K 31/704 (2013.01); A61K 9/0085 (2013.01); A61K 9/5138 (2013.01); A61K 9/5153 (2013.01); A61K 9/5161 (2013.01); A61K 9/5169 (2013.01); A61K 31/136 (2013.01)

Citation (search report)

See references of WO 0074658A1

Designated contracting state (EPC)

CH DE ES FR GB IT LI NL SE

EPO simple patent family

WO 0074658 A1 20001214; AU 4373499 A 20001228; EP 1100475 A1 20010523; JP 2003501379 A 20030114

INPADOC legal status


2008-01-11 [REG HK WD] APPLICATIONS WITHDRAWN, DEEMED TO BE WITHDRAWN, OR REFUSED AFTER PUBLICATION IN HONG KONG

- Document: HK 1037962

2004-10-13 [18R] REFUSED

- Effective date: 20040426

2003-07-02 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20030516

2001-09-19 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: NANOPHARM AG

2001-05-23 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010131

2001-05-23 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): CH DE ES FR GB IT LI NL SE